<DOC>
	<DOCNO>NCT01587573</DOCNO>
	<brief_summary>The purpose study verify discriminatory value previously identify salivary transcriptome proteome marker oral squamous cell cancer intend use population patient oral lesion suspicious cancer .</brief_summary>
	<brief_title>Developing In-vitro Diagnostic Risk-Stratification Test Oral Cancer</brief_title>
	<detailed_description>Saliva sample collect patient clinically driven oral biopsy lesion suspicious cancer . Specimens process laboratory personnel blind tissue diagnosis . Six pre-specified mRNA marker ( IL1b , IL8 , SAT , DUSP1 , OAZ1 S100P ) measure polymerase chain reaction . Markers compare cancer control raw Ct value well delta Ct adjustment housekeep gen . Appropriate housekeep gene identify random subset cancer control patient verify remain subject . Predictive model generate pre-specified method robustness evaluate bootstrap analysis . The model validate second cohort . Three pre-specified protein marker ( IL8 , IL1B , M2BP ) secondary endpoint also compare cancer control patient .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<criteria>Adult patient schedule biopsy oral lesion suspicious squamous cell cancer Patients know prior oral malignancy last 2 year cancer last 5 year non melanoma skin cancer immune deficiency</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>salivary biomarkers</keyword>
</DOC>